Keyphrases
Headache
100%
Magnetic Resonance Imaging
100%
Brain Tumor
100%
Diagnostic Strategy
100%
Cost-effectiveness Analysis
100%
Life-years Gained
87%
Quality-adjusted Life Years
87%
Neuroimaging
50%
Prior Probability
50%
Clinical Follow-up
37%
Low Risk
25%
Effective Strategies
25%
Intermediate Risk
25%
Cost-effectiveness Ratio
25%
Neurological Examination
25%
Children at Risk
12%
Computed Tomography
12%
Economic Consequences
12%
High Risk
12%
Imaging Strategy
12%
Clinical High Risk
12%
Clinical Predictors
12%
Markov Model
12%
Progression Rate
12%
Cost Savings
12%
Patient Selection
12%
Group-based
12%
Quality-adjusted Life Expectancy
12%
Decision-analytic Model
12%
Clinical Variables
12%
Incremental Cost
12%
Reasonable Cost
12%
Clinical Consequences
12%
Migraine Headache
12%
Tumor Survival
12%
Model Effectiveness
12%
Non-migraine Headache
12%
Medicine and Dentistry
Diagnosis
100%
Cost-Effectiveness Analysis
100%
Magnetic Resonance Imaging
100%
Headache
100%
Intracranial Tumor
100%
Quality Adjusted Life Year
87%
Health Care Cost
75%
High Risk Population
25%
Neurologic Examination
25%
Neoplasm
12%
Predictor
12%
Computer Assisted Tomography
12%
Life Expectancy
12%
Sensitivity and Specificity
12%
Migraine
12%
Neuroscience
Magnetic Resonance Imaging
100%
Headache
100%
Intracranial Tumor
100%
Predictor
12%
Computed Tomography
12%
Markov Models
12%
Migraine
12%
Pharmacology, Toxicology and Pharmaceutical Science
Headache
100%
Intracranial Tumor
100%
Life Expectancy
14%
Neoplasm
14%
Migraine
14%
Psychology
Magnetic Resonance Imaging
100%
Neuroimaging
50%
Neurologic Examination
25%
Tomography
12%
Markov Model
12%